QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
QQQ   269.87 (-0.16%)
AAPL   446.85 (-0.90%)
MSFT   207.28 (-0.47%)
FB   265.11 (+0.80%)
GOOGL   1,507.62 (+0.72%)
AMZN   3,150.66 (+0.08%)
NVDA   443.08 (-0.79%)
CGC   17.62 (-1.73%)
BABA   252.17 (+1.62%)
TSLA   1,414.53 (-0.28%)
GE   6.86 (+2.85%)
MU   48.69 (-0.94%)
AMD   79.88 (-2.87%)
T   30.36 (+0.53%)
F   7.27 (+2.54%)
ACB   10.10 (-1.17%)
GILD   68.36 (-0.22%)
NFLX   477.47 (-1.22%)
DIS   131.29 (+1.94%)
BAC   27.32 (+2.86%)
BA   185.80 (+3.56%)
Log in

NASDAQ:CDLXCardlytics Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
$65.82
MA: $71.34
$79.17
52-Week Range N/A
Volume565,411 shs
Average Volume580,994 shs
Market Capitalization$1.81 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.39
Cardlytics, Inc. operates a purchase intelligence platform in the United States and the United Kingdom. It operates in two segments, Cardlytics Direct and Other Platform Solutions. The company's platform is the Cardlytics Direct solution, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. It also provides solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is headquartered in Atlanta, Georgia.
Read More
Cardlytics logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.1Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.78 out of 5 stars


Industry, Sector and Symbol

Industry Computer programming, data processing, & other computer related
Sub-IndustryN/A
Current SymbolNASDAQ:CDLX
CUSIPN/A
Phone888-798-5802

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$210.43 million
Book Value$6.28 per share

Profitability

Net Income$-17,140,000.00

Miscellaneous

EmployeesN/A
Market Cap$1.81 billion
Next Earnings Date11/10/2020 (Estimated)
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive CDLX News and Ratings via Email

Sign-up to receive the latest news and ratings for CDLX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cardlytics (NASDAQ:CDLX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Cardlytics?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cardlytics in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Cardlytics
.

When is Cardlytics' next earnings date?

Cardlytics is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020.
View our earnings forecast for Cardlytics
.

How were Cardlytics' earnings last quarter?

Cardlytics Inc (NASDAQ:CDLX) released its quarterly earnings results on Tuesday, August, 4th. The company reported ($0.38) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.74) by $0.36. The business earned $28.22 million during the quarter, compared to the consensus estimate of $30.84 million. Cardlytics had a negative return on equity of 26.42% and a negative net margin of 18.86%. The company's quarterly revenue was down 42.1% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.12) EPS.
View Cardlytics' earnings history
.

What price target have analysts set for CDLX?

6 analysts have issued twelve-month target prices for Cardlytics' shares. Their forecasts range from $26.00 to $75.00. On average, they anticipate Cardlytics' share price to reach $55.17 in the next twelve months.
View analysts' price targets for Cardlytics
.

Has Cardlytics been receiving favorable news coverage?

Media headlines about CDLX stock have been trending neutral on Tuesday, according to InfoTrie. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cardlytics earned a news sentiment score of 0.2 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future.
View the latest news about Cardlytics
.

Are investors shorting Cardlytics?

Cardlytics saw a decrease in short interest in the month of January. As of January 31st, there was short interest totaling 2,770,000 shares, a decrease of 19.5% from the January 15th total of 3,440,000 shares. Based on an average daily trading volume, of 559,900 shares, the short-interest ratio is currently 4.9 days.
View Cardlytics' Short Interest
.

Who are some of Cardlytics' key competitors?

What other stocks do shareholders of Cardlytics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardlytics investors own include Alibaba Group (BABA), NVIDIA (NVDA), Trade Desk (TTD), Caterpillar (CAT), Walt Disney (DIS), Docusign (DOCU), Advanced Micro Devices (AMD), Roku (ROKU), Square (SQ) and Twilio (TWLO).

Who are Cardlytics' key executives?

Cardlytics' management team includes the following people:
  • Mr. Scott D. Grimes, Co-Founder, CEO & Director (Age 56)
  • Ms. Lynne Marie Laube, Co-Founder, COO & Director (Age 49)
  • Mr. David Evans, CFO & Head of Corp. Devel.
  • Mr. Sathish Gaddipati, Chief Technology Officer (Age 52)
  • Mr. Kirk L. Somers, Chief Legal & People Officer (Age 54)

When did Cardlytics IPO?

(CDLX) raised $76 million in an IPO on Friday, February 9th 2018. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. BofA Merrill Lynch and J.P. Morgan acted as the underwriters for the IPO and Wells Fargo Securities, SunTrust Robinson Humphrey, Raymond James and KeyBanc Capital Markets were co-managers.

What is Cardlytics' stock symbol?

Cardlytics trades on the NASDAQ under the ticker symbol "CDLX."

Who are Cardlytics' major shareholders?

Cardlytics' stock is owned by a number of institutional and retail investors. Top institutional investors include Frontier Capital Management Co. LLC (1.67%), Jennison Associates LLC (1.63%), Victory Capital Management Inc. (1.16%), Great Lakes Advisors LLC (0.72%), Ziegler Capital Management LLC (0.34%) and New York State Common Retirement Fund (0.30%). Company insiders that own Cardlytics stock include Aimia Inc, Andrew Christiansen, Bryce Youngren, Clifford Sosin, David Leslie Adams, David Thomas Evans, John L Jr Klinck, John V Balen, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Polaris Venture Management Co, Scott D Grimes and Tony Weisman.
View institutional ownership trends for Cardlytics
.

Which major investors are selling Cardlytics stock?

CDLX stock was sold by a variety of institutional investors in the last quarter, including RMB Capital Management LLC, Frontier Capital Management Co. LLC, Hancock Whitney Corp, Hussman Strategic Advisors Inc., Jennison Associates LLC, and Brave Asset Management Inc.. Company insiders that have sold Cardlytics company stock in the last year include Aimia Inc, Andrew Christiansen, Bryce Youngren, David Leslie Adams, David Thomas Evans, John L Jr Klinck, Kirk Somers, Lynne Marie Laube, Mark A Johnson, Scott D Grimes, and Tony Weisman.
View insider buying and selling activity for Cardlytics
.

Which major investors are buying Cardlytics stock?

CDLX stock was bought by a variety of institutional investors in the last quarter, including Great Lakes Advisors LLC, First Trust Advisors LP, Serengeti Asset Management LP, Tygh Capital Management Inc., Ziegler Capital Management LLC, Roubaix Capital LLC, Victory Capital Management Inc., and Calamos Advisors LLC. Company insiders that have bought Cardlytics stock in the last two years include Clifford Sosin, and John V Balen.
View insider buying and selling activity for Cardlytics
.

How do I buy shares of Cardlytics?

Shares of CDLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Cardlytics?

Cardlytics has a market capitalization of $0.00 and generates $210.43 million in revenue each year. The company earns $-17,140,000.00 in net income (profit) each year or ($0.75) on an earnings per share basis.

What is Cardlytics' official website?

The official website for Cardlytics is www.cardlytics.com.

How can I contact Cardlytics?

Cardlytics' mailing address is 675 PONCE DE LEON AVENUE NE SUITE 6000, ATLANTA GA, 30308. The company can be reached via phone at 888-798-5802 or via email at [email protected]

This page was last updated on 8/11/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.